PAYMENT REVIEW OF

SINGAPORE BIOTECHNOLOGY PTE. LTD.

18 JANUARY 2026

SINGAPORE BIOTECHNOLOGY PTE. LTD. (ABN: 201429555M) is a business entity in Singapore registered with The Accounting and Corporate Regulatory Authority (ACRA) and is currently operational. It has a payment reputation rating of 'A' under our scoring framework, and all transactions are recorded in Singapore Dollars (SGD).
Good: 11

Registrar Details

Entity Name
SINGAPORE BIOTECHNOLOGY PTE. LTD.
UEN
201429555M
Entity Status
Live Company
Constitution
Data unavailable
Entity Type
Local Company
Primary Activity (SSIC)
46306
Wholesale of health supplements
Secondary Activity (SSIC)
46900
Wholesale trade of a variety of goods without a dominant product
Issuance Agency
ACRA
Registration Incorporation Date
03 October 2014
UEN Issue Date
03 October 2014
Registered Address
101A UPPER CROSS STREET PEOPLE'S PARK CENTRE #13-14 SINGAPORE 58358
Number of Officers
6
Financial Reporting
Account Due Date
30 April 2026
Annual Return Date
10 April 2025
Audit Firms
Data unavailable
Former Names
Data unavailable

User Reviews
0

Loading reviews...

Review Anonymously

Help others understand SINGAPORE BIOTECHNOLOGY PTE. LTD.'s payment practices.
A
Payment Rating

Going Concern

PASSED

Legal Name

SINGAPORE BIOTECHNOLOGY PTE. LTD.

Registration Number

201429555M

Country Jurisdiction

SINGAPORE

Registered Date

03 OCTOBER 2014 (11 years 6 months ago)

Base Currency

SINGAPORE DOLLARS

Last Updated

18 JANUARY 2026 10:57 PM

Legal Invoice Recovery
Make a claim on SINGAPORE BIOTECHNOLOGY PTE. LTD.

Frequently Asked Questions

The Payment Rating of SINGAPORE BIOTECHNOLOGY PTE. LTD. is A. It is a proprietary metric aggregating verified public sources (court judgements, news media, financial analysis), community feedback and data partnerships. It indicates the likelihood of on-time payments but is not a financial guarantee.

SINGAPORE BIOTECHNOLOGY PTE. LTD. has passed the "Going Concern" test. This suggest that SINGAPORE BIOTECHNOLOGY PTE. LTD. is operationally active and is likely to be able to meet financial obligations. More specifically, it means SINGAPORE BIOTECHNOLOGY PTE. LTD. does not have significant reported poor payment reviews that is cause for distress and it is also not in the process of being liquidated, winding up, or struck off from the government registry.

Based on the registration date of 03 OCTOBER 2014 12:00 AM, SINGAPORE BIOTECHNOLOGY PTE. LTD. is approximately 12 years old.

The business registration number of SINGAPORE BIOTECHNOLOGY PTE. LTD. is 201429555M. The business registration number is a standard identification number assigned by government registrar to uniquely identify a business entity.

SINGAPORE BIOTECHNOLOGY PTE. LTD. is officially located at 101A UPPER CROSS STREET PEOPLE'S PARK CENTRE #13-14 SINGAPORE 58358. This is the registered address on file with the registrar.

SINGAPORE BIOTECHNOLOGY PTE. LTD.'s primary industry is Wholesale of health supplements (SSIC code: 46306) and secondary industry is Wholesale trade of a variety of goods without a dominant product (SSIC code: 46900).

No. We are an open business directory and review platform. We do not issue credit ratings like Experian, Equifax, or Moody's. Our data, including Payment Ratings, should be used for reference only, not as the sole basis for financial decisions.

Business profile information is provided by official government registries, such as ACRA in Singapore, Australian Business Register, New Zealand Companies Register, and Companies House in the United Kingdom. Payment ratings and reviews are sourced from court notices or judgements, news media, financial analysis, data partnerships and user reported reviews.

Yes. Your identity is protected—reviews are published under the display name 'Anonymous' so businesses cannot identify who wrote them.​ While we verify that reviewers have a legitimate connection to the business (such as being a real supplier or customer), this verification happens privately and is never shared publicly. This approach mirrors how Glassdoor (and Reddit) protects reviewers from retaliation while ensuring reviews come from real people. Avoid including identifying details in your review text (like specific invoice numbers, unique transaction dates, or your company name) that could make you recognizable.

As an open platform, Payre democratizes payment risk information that would otherwise be expensive or difficult to access through traditional credit bureaus. You can share and read actual creditor experiences about late or non-payments to promote a prompt payment culture, influence debtor's management practice and help others make better decisions. We promise reviews to remain freely accessible to anyone.